The time it takes to experience the benefits of tVNS® E varies depending on the indication being treated and the individual response of the patient.

Expected Benefits for Specific Conditions #

• Epilepsy – Clinical studies have shown tVNS® patients experienced a minimum 25% reduction in seizure frequency after a 20-week treatment period.
• Depression – Patients undergoing psychopharmacological and psychotherapy treatments alongside tVNS® have reported a reduction in the Hamilton Depression Rating Scale (HAMD) score by 2-3 points after 9 weeks of use.
• Prader-Willi Syndrome (PWS) – Clinical studies show that patients experienced a 50% reduction in temper outbursts after 12 months of treatment.
• Migraines – Studies show that tVNS® patients experienced a reduction of the frequency of days with migraine of 50% after a treatment period of 12 weeks.

tVNS® E Is Not an Acute Treatment #

tVNS® E is designed for long-term use and does not provide immediate relief. Even in patients who respond well, noticeable improvements often occur gradually over the course of several weeks to months.

Consistency Is Key #

To maximize potential benefits, we strongly recommend adhering to the daily stimulation recommendation of 4 hours, especially in the first few months of treatment. Regular use is crucial to determining whether tVNS® E has a positive impact on your condition.If you have any concerns about your progress, we encourage you to consult your healthcare provider for further guidance.